ALTIERI, Barbara
 Distribuzione geografica
Continente #
AS - Asia 1.507
SA - Sud America 447
NA - Nord America 371
EU - Europa 178
AF - Africa 124
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.628
Nazione #
SG - Singapore 750
BR - Brasile 342
US - Stati Uniti d'America 334
HK - Hong Kong 302
VN - Vietnam 191
CN - Cina 164
ZA - Sudafrica 104
NL - Olanda 102
AR - Argentina 48
IT - Italia 28
MX - Messico 19
IQ - Iraq 18
EC - Ecuador 16
BD - Bangladesh 15
IN - India 15
CO - Colombia 12
ID - Indonesia 10
CA - Canada 9
DE - Germania 8
RU - Federazione Russa 8
PE - Perù 7
EG - Egitto 6
GB - Regno Unito 6
JP - Giappone 6
PY - Paraguay 6
UA - Ucraina 6
VE - Venezuela 6
PK - Pakistan 5
UZ - Uzbekistan 5
BA - Bosnia-Erzegovina 4
CL - Cile 4
KE - Kenya 4
MA - Marocco 4
MY - Malesia 4
PL - Polonia 4
AZ - Azerbaigian 3
BO - Bolivia 3
ES - Italia 3
SA - Arabia Saudita 3
TR - Turchia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
EE - Estonia 2
FR - Francia 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
JO - Giordania 2
QA - Qatar 2
TN - Tunisia 2
AL - Albania 1
CG - Congo 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.628
Città #
Hong Kong 300
Singapore 269
Ashburn 102
Johannesburg 100
Ho Chi Minh City 61
Dallas 44
Hanoi 37
Beijing 27
São Paulo 26
Los Angeles 16
Rio de Janeiro 16
Columbus 15
Hefei 14
Buffalo 10
Des Moines 10
Mexico City 8
New York 8
Belo Horizonte 7
Brasília 7
Brooklyn 7
Can Tho 7
Curitiba 7
Milan 7
Biên Hòa 6
Guayaquil 6
Parma 6
Würzburg 6
Asunción 5
Baghdad 5
Da Nang 5
Haiphong 5
Lima 5
Salvador 5
San Francisco 5
Wuhan 5
Zhengzhou 5
Buenos Aires 4
Changsha 4
Chicago 4
Denver 4
Erbil 4
Fortaleza 4
Montreal 4
Nairobi 4
Quito 4
Shijiazhuang 4
Tashkent 4
Thái Bình 4
Warsaw 4
Baku 3
Boardman 3
Bogotá 3
Cairo 3
Campinas 3
Canoas 3
Chennai 3
Guarulhos 3
Joinville 3
Karachi 3
La Paz 3
Medellín 3
Montevideo 3
Orem 3
Phoenix 3
Phú Thọ 3
Piracicaba 3
Secaucus 3
São José 3
São José dos Campos 3
Tianjin 3
Tokyo 3
Abu Dhabi 2
Agrolândia 2
Alexandria 2
Americana 2
Amman 2
Arequipa 2
Bady Bassitt 2
Barranquilla 2
Blumenau 2
Boituva 2
Bình Dương 2
Bắc Giang 2
Bắc Ninh 2
Cabo Frio 2
Cape Town 2
Carapicuíba 2
Casablanca 2
Caçapava 2
Conselheiro Lafaiete 2
Coronel Brandsen 2
Cravinhos 2
Criciúma 2
Cuiabá 2
Dnipro 2
Doha 2
Feira de Santana 2
Forquilhinha 2
General Alvear 2
Gravataí 2
Totale 1.350
Nome #
Machine learning-based survival prediction tool for adrenocortical carcinoma 67
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 51
Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management 51
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma 51
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma 41
SOX2+ sustentacular cells are stem cells of the postnatal adrenal medulla 41
4. Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 40
Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer 39
Chronic low-dose glucocorticoid inhalatory therapy as a cause of bone loss in a young man: case report 37
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 37
Circulating microRNA Expression in Cushing's Syndrome 37
Recovery of hypopituitarism in macroprolactinomas: a comparison of medical vs. surgical treatment. Results from a European multicenter study 36
"Expression and prognostic relevance of PD-1, PD-L1 and CTLA-4 immune checkpoints in adrenocortical carcinoma" 36
Medical therapy of endogenous Cushing's syndrome with steroidogenesis inhibitors: treatment rationale, available drugs, and therapeutic effects 36
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma 35
Adrenal disorders: Is there Any role for vitamin D? 35
Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept 35
Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies 34
An Italian Survey of compliance with major guidelines for L-thyroxine of primary hypothyroidism 34
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy 33
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study 33
Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study 33
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 33
ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas 33
Next-generation therapies for adrenocortical carcinoma 33
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 32
The role of Insulin-like Growth Factor (IGF) system in the adrenocortical tumors 32
Sex differences in carcinoid syndrome: A gap to be closed 32
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 32
Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors 31
Single-nucleus and spatial transcriptome reveal adrenal homeostasis in normal and tumoral adrenal gland 31
Calcium and vitamin D supplementation. Myths and realities with regard to cardiovascular risk 30
Low bone mineral density in a growth hormone deficient (GHD) adolescent 30
Leydig cell tumour and giant adrenal myelolipoma associated with adrenogenital syndrome: a case report with a review of the literature 29
Nutrition and neuroendocrine tumors: an update of the literature 29
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection 28
Notch1 pathway in adrenocortical carcinomas: correlation with clinical outcome 28
Vitamin D and chronic diseases: the current state of the art 28
Chronotype and cardio metabolic health in obesity: does nutrition matter? 28
Calcitonin in thyroid and extra-thyroid Neuroendocrine Neoplasms: the two-faced Janus 27
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 27
Clinical and penile Doppler outcomes using a modified, tourniquet free, Nesbit plication for severe Peyronie's disease 27
Adrenocortical tumors and insulin resistance. What is the first step? 27
Prognostic role of targeted methylation analysis in paraffin-embedded samples of adrenocortical carcinoma 27
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors 26
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study 26
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm 26
The interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma 26
Cellular landscape of adrenocortical carcinoma at single-nuclei resolution 26
Gemcitabine-Based Chemotherapy In Adrenocortical Carcinoma: A Multicentric Study On Efficacy and Predictive Factors 26
Outcome of Immunotherapy in Adrenocortical Carcinoma - A retrospective cohort study 26
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma 25
Does vitamin D play a role in Autoimmune Endocrine Disorders? A proof of concept 25
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma 25
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 24
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma 24
Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma 24
Targeted molecular analysis in adrenocortical carcinomas: a strategy towards improved personalized prognostication 23
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma 23
Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study 23
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 23
Focus on vitamin D and the adrenal gland 23
Effects of germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on mitotane treatment in adrenocortical carcinoma: a multicenter ENSAT study 23
Consecutive adrenal Cushing´s syndrome and Cushing´s disease in a patient with somatic CTNNB1, USP8, and NR3C1 mutations 22
Shedding new light on female fertility: The role of vitamin D 22
Editorial: Endocrine malignancies: from pathophysiology to current clinical and surgical therapeutic approaches 22
Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety 22
Integrative genomic analysis reveals a conserved role for prolactin signalling in the regulation of adrenal function 22
RNA-Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights 22
Special Issue: Present and Future of Personalised Medicine for Endocrine Cancers 22
null 22
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma 21
Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC-MS/MS in Patients with Adrenocortical Carcinoma 21
Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 21
Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study 21
Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism 21
Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of Diabetes Mellitus and Pancreatic Cancer 20
Management of Patients with Glucocorticoid-Related Diseases and COVID-19 20
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question 20
Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1 20
Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma 20
Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing's Syndrome: Results From a Single Center Cohort Study 19
Novel AIP mutation in exon 6 causing acromegaly in a German family 19
Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study 19
Current evidence on vitamin D deficiency and kidney transplant: What's new? 19
Morbidity in Patients with Chronic Adrenal Insufficiency - Cardiovascular Risk Factors and Hospitalization Rate Compared to Population Based Controls 19
Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study 19
Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness 19
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 18
Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation 18
Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma 18
CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma 18
Targeted gene expression profile reveals CDK4 as therapeutic target for selected patients with adrenocortical carcinoma 17
Current Evidence on Local Therapies in Advanced Adrenocortical Carcinoma 17
Expression of SOAT1 in adrenocortical carcinoma and response to mitotane monotherapy: an ENSAT multicenter study 17
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors 17
Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning 16
The Importance of Being a ‘Lark' in Post-Menopausal Women with Obesity: A Ploy to Prevent Type 2 Diabetes Mellitus? 15
Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: Impact on poor prognosis and impaired responsiveness to immunotherapy 14
Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports 12
Totale 2.704
Categoria #
all - tutte 8.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025875 0 0 0 0 0 0 0 0 275 206 50 344
2025/20261.860 178 439 479 262 491 11 0 0 0 0 0 0
Totale 2.735